tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ITOS is currently covered by 5 analysts with an average price target of $19.53. This is a potential upside of $9.38 (92.41%) from yesterday's end of day stock price of $10.15.
Iteos Therapeutics 's activity chart (see below) currently has 39 price targets and 33 ratings on display. The stock rating distribution of ITOS is 42.86% BUY and 57.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.17% with an average time for these price targets to be met of 82.17 days.
Highest price target for ITOS is $15, Lowest price target is $9, average price target is $12.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 28-May-2025. First documented stock forecast 18-Aug-2020.
Currently out of the existing stock ratings of ITOS, 3 are a BUY (42.86%), 4 are a HOLD (57.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-May-2025
$12
$1.85 (18.23%)
$18
9 months 4 days ago
(28-May-2025)
2/7 (28.57%)
$1.94 (19.28%)
281
Hold Since 14-May-2025
$9
$-1.15 (-11.33%)
$59
9 months 18 days ago
(14-May-2025)
1/3 (33.33%)
$1.4 (18.42%)
14
Hold Since 14-May-2025
9 months 18 days ago
(14-May-2025)
1/9 (11.11%)
$13.26 (171.32%)
198
Hold Since 13-May-2025
$15
9 months 19 days ago
(13-May-2025)
0/5 (0%)
$7.9 (111.27%)
Buy Since 12-Aug-2024
$15
$4.85 (47.78%)
$24
11 months 26 days ago
(06-Mar-2025)
0/2 (0%)
$7.9 (111.27%)
What is ITOS (Iteos Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?
Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?
Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?
